Counterfeits quantified

$75 billion. That's an estimate of the revenue generated in the 2010 counterfeit drug market, according to The Center for Medicine in the Public Interest. The center's president, former FDA associate commissioner Peter Pitts, bases the figure on government information. He projects growth of 20% annually in the coming years. News

Sponsored By Digital Pharma Europe

Fierce Pharma Marketing is excited to announce the first virtual Digital Pharma Europe!

This summit will profile best-in-class case studies and senior-level discussions from leaders who are innovating the way we look at the intersection of digital technologies and marketing in Europe.